Lexaria Bioscience Corp Stock Price Prediction

LEXX Stock  USD 2.08  0.01  0.48%   
The RSI of Lexaria Bioscience's share price is below 30 at this time. This indicates that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Lexaria Bioscience Corp, making its price go up or down.

Oversold Vs Overbought

29

 
Oversold
 
Overbought
The successful prediction of Lexaria Bioscience's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Lexaria Bioscience Corp, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Lexaria Bioscience's stock price prediction:
Wall Street Target Price
10
Quarterly Revenue Growth
0.081
Using Lexaria Bioscience hype-based prediction, you can estimate the value of Lexaria Bioscience Corp from the perspective of Lexaria Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lexaria Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Lexaria because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lexaria Bioscience after-hype prediction price

    
  USD 1.95  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Lexaria Bioscience Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexaria Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.173.316.64
Details
Naive
Forecast
LowNextHigh
0.042.115.44
Details
2 Analysts
Consensus
LowTargetHigh
6.377.007.77
Details

Lexaria Bioscience After-Hype Price Prediction Density Analysis

As far as predicting the price of Lexaria Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lexaria Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lexaria Bioscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Lexaria Bioscience Estimiated After-Hype Price Volatility

In the context of predicting Lexaria Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lexaria Bioscience's historical news coverage. Lexaria Bioscience's after-hype downside and upside margins for the prediction period are 0.10 and 5.28, respectively. We have considered Lexaria Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.08
1.95
After-hype Price
5.28
Upside
Lexaria Bioscience is unstable at this time. Analysis and calculation of next after-hype price of Lexaria Bioscience Corp is based on 3 months time horizon.

Lexaria Bioscience Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Lexaria Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lexaria Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lexaria Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.83 
3.33
  0.13 
  0.05 
11 Events / Month
9 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.08
1.95
6.25 
2,081  
Notes

Lexaria Bioscience Hype Timeline

Lexaria Bioscience Corp is now traded for 2.08. The entity has historical hype elasticity of -0.13, and average elasticity to hype of competition of 0.05. Lexaria is anticipated to decline in value after the next headline, with the price expected to drop to 1.95. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -6.25%, whereas the daily expected return is now at -0.83%. The volatility of related hype on Lexaria Bioscience is about 5067.39%, with the expected price after the next announcement by competition of 2.13. The book value of the company was now reported as 0.64. The company recorded a loss per share of 0.47. Lexaria Bioscience Corp last dividend was issued on the 12th of January 2021. The entity had 1:30 split on the 12th of January 2021. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days.
Check out Lexaria Bioscience Basic Forecasting Models to cross-verify your projections.

Lexaria Bioscience Related Hype Analysis

Having access to credible news sources related to Lexaria Bioscience's direct competition is more important than ever and may enhance your ability to predict Lexaria Bioscience's future price movements. Getting to know how Lexaria Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lexaria Bioscience may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
REVBRevelation Biosciences(0.03)3 per month 0.00 (0.11) 8.97 (7.83) 34.52 
ZURAZura Bio Limited(0.21)9 per month 0.00 (0.10) 7.95 (7.94) 26.70 
PHIOPhio Pharmaceuticals Corp(0.19)6 per month 5.56 (0) 11.78 (9.23) 36.22 
ZVSAZyVersa Therapeutics(0.1)4 per month 0.00 (0.15) 7.57 (9.60) 78.93 
RNAZTranscode Therapeutics(0.02)5 per month 6.97  0.06  22.00 (11.43) 68.80 
IMMXImmix Biopharma(0.04)4 per month 4.54 (0.01) 9.38 (8.22) 32.68 
CNSPCns Pharmaceuticals(0.01)6 per month 0.00 (0.06) 9.09 (8.33) 39.29 
EFTREffector Therapeutics(0.06)4 per month 0.00 (0.31) 8.70 (27.78) 88.91 
NAVBNavidea Biopharmaceuticals 0.00 0 per month 0.00 (0.15) 12.50 (12.50) 40.40 
SONNSonnet Biotherapeutics Holdings 1.15 6 per month 0.00 (0.17) 12.31 (9.79) 37.58 
ICULMF Acquisition Opportunities(0.12)12 per month 0.00 (0.20) 7.98 (6.93) 31.31 
VIRIVirios Therapeutics Llc 0.14 5 per month 0.00 (0.06) 12.46 (10.62) 50.54 
BDRXBiodexa Pharmaceticals 0.40 9 per month 0.00 (0.08) 13.30 (17.24) 97.78 
ONCROncorus 0.01 3 per month 0.00 (0.16) 10.00 (21.20) 120.67 

Lexaria Bioscience Additional Predictive Modules

Most predictive techniques to examine Lexaria price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lexaria using various technical indicators. When you analyze Lexaria charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lexaria Bioscience Predictive Indicators

The successful prediction of Lexaria Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lexaria Bioscience Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lexaria Bioscience based on analysis of Lexaria Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lexaria Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lexaria Bioscience's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding288.38282.77121.4426.35
PTB Ratio2.192.286.0354.87

Story Coverage note for Lexaria Bioscience

The number of cover stories for Lexaria Bioscience depends on current market conditions and Lexaria Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lexaria Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lexaria Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Lexaria Bioscience Short Properties

Lexaria Bioscience's future price predictability will typically decrease when Lexaria Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lexaria Bioscience Corp often depends not only on the future outlook of the potential Lexaria Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lexaria Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.4 M
Cash And Short Term Investments6.6 M

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.